ImageneBio IMA Cash Flow Statement (2020-2025)

NASDAQ IMA
$4.13 +0.13 (+3.25%)
At close: Oct 20, 2026 · 4:00 PM EDT
Reported Financials

ImageneBio Quarterly Cash Flow Statement

Periods 24 quarters
Latest Dec 2025

ImageneBio cash flow statement data for the quarter ended Dec 2025. This cash flow statement covers 24 quarters of results from Mar 2020 through Dec 2025, standardized by Business Quant from the company’s SEC filings.

Cash Flow StatementCash Flow Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025
Operating Activities
Net Income
-9.72M-12.68M-14.52M2.80M-16.84M-20.49M-17.34M-14.10M-14.22M-17.12M-17.34M-19.49M-16.15M-13.73M-1.88M-17.48M-6.08M-7.59M-24.78M
Depreciation and DepletionDep. & Depletion
0.10M0.10M0.10M0.16M0.18M0.15M0.21M0.21M0.23M0.24M0.24M0.31M0.22M0.09M0.09M0.10M0.09M0.09M
Depreciation, Depletion & Amortization
Depreciation & Amortization (CF)Dep. & Amort.
0.10M0.10M0.10M0.16M0.18M0.15M0.21M0.21M0.23M0.24M0.24M0.31M0.22M0.09M0.09M0.10M0.00M0.00M0.00M
Share-based CompensationStock Comp.
0.89M1.26M1.45M1.58M1.90M1.96M1.81M1.86M2.00M1.88M2.00M1.76M2.00M1.28M1.02M5.30M0.06M15.28M
Gains from Sales and DivestituresGains Divest
-0.10M-1.19M1.19M
Asset Writedowns and ImpairmentWritedown
0.74M
Other non-cash itemsOther Non-Cash
0.27M0.30M0.30M0.31M0.35M0.34M0.36M0.28M0.34M0.34M0.47M0.56M0.45M0.46M-0.59M1.74M0.20M0.36M-0.23M
Change in Working Capital
Change in ReceivablesChange Receivables
0.09M0.06M0.30M0.30M0.31M0.32M0.33M0.34M0.35M0.36M0.63M0.75M
Change in Account PayablesChange Payables
0.05M0.40M-0.55M0.46M0.00M0.95M-1.16M-0.09M0.67M-0.99M-0.67M-1.88M-0.16M-0.50M-1.58M1.07M1.43M-0.46M-3.14M
Change in Accured ExpensesChange Accured Exp.
-1.81M0.94M0.48M1.70M-1.52M0.83M3.51M-0.59M-2.92M0.91M-3.30M-2.35M-3.76M-1.72M4.76M-1.75M-0.31M0.29M-9.93M
Change in Other Operating AssetsOther Assets Change
-0.62M2.48M1.26M-0.15M0.17M2.66M-2.11M-0.56M-0.31M0.46M-0.99M0.83M0.37M-2.63M2.37M-2.89M1.79M4.41M-1.36M
Change in Other Operating LiabilitiesOther Liabilities Change
-3.47M-3.55M-3.75M-20.22M-3.38M-0.38M-6.40M-5.45M-5.66M-2.36M-1.82M-1.32M-0.98M-0.58M1.87M-3.41M-0.73M-0.09M-0.51M
Other Working Capital ChangesOther WC Changes
-2.85M-6.03M-5.00M-20.07M-3.55M-3.04M-4.30M-4.90M-5.35M-2.82M-0.83M-2.15M-1.35M2.04M-0.50M-0.52M-2.53M-4.50M0.85M
Cash from OperationsCash from Ops.
-13.17M-15.72M-17.99M-13.37M-19.78M-19.45M-17.22M-17.66M-19.78M-18.14M-20.00M-21.82M-18.30M-12.50M12.96M-28.16M-7.23M-11.90M-21.50M
Investing Activities
Capital ExpendituresCapex
0.84M0.19M0.18M0.55M0.03M0.04M1.13M0.23M0.15M0.26M
Sales of Property, Plant and EquipmentPP&E (Sale)
0.06M0.19M0.62M-0.43M
Change in Property, Plant and EquipmentChange in PP&E
-0.84M-0.19M-0.18M-0.55M-0.03M-0.04M-1.13M-0.23M-0.15M-0.26M0.06M0.19M0.62M-0.43M
Purchase of InvestmentsInvestments Purchased
166.02M8.98M14.87M26.48M41.73M5.32M18.17M24.84M62.30M9.97M-72.27M88.30M1.49M
Sale and Maturity of InvestmentsInvestments Sold
51.78M37.21M31.07M28.00M50.06M45.48M13.50M13.70M-17.05M50.31M2.25M
Cash from Investing ActivitiesCash from Investing
-0.84M-0.19M-0.18M-0.55M-166.05M20.49M35.78M10.50M-10.81M22.68M31.89M20.38M-48.74M3.92M55.84M-45.92M-4.45M
Financing Activities
Change in Capital Stock
Common Stock IssuedStock Issued
132.67M-1.10M0.07M0.24M0.50M0.58M0.02M0.00M-0.11M0.05M
Net Shares Issued and RepurchasedNet Shares Issued
132.67M-1.10M0.07M0.24M0.50M0.58M0.02M0.00M-0.11M0.05M
Net Equity Issued and RepurchasedNet Equity Issued
132.67M-1.10M0.07M0.24M0.50M0.58M0.02M0.00M-0.11M0.05M
Other financing activitiesOther financing
-0.15M-0.02M-1.98M-52.63M
Cash from Financing ActivitiesCash from Financing
132.53M-1.10M0.07M0.24M0.50M0.58M0.02M0.00M38.92M0.06M0.03M13.02M122.42M
Additional items
Exchange Rate EffectFX Effect
0.00M-0.01M0.66M
Change in Cash
118.52M-17.01M-18.11M-13.68M-185.34M1.61M18.59M-7.16M-30.59M41.54M50.82M-1.38M-67.04M-8.58M68.92M-74.20M-7.20M1.10M97.14M
Ending Cash Balance
281.88M264.88M246.77M233.09M47.75M49.36M67.95M60.79M30.20M71.74M122.56M15.32M54.13M45.55M8.73M12.12M4.92M6.02M103.16M94.53M
Free Cash FlowFCF
-14.01M-15.91M-18.17M-13.92M-19.82M-19.49M-18.35M-17.89M-19.94M-18.14M-20.00M-22.08M-18.30M-12.50M12.96M-28.16M-7.23M-11.90M-21.50M
Net Cash FlowNCF
118.52M-17.01M-18.11M-13.68M-185.34M1.61M18.59M-7.16M-30.59M4.54M50.82M-1.38M-67.04M-8.58M68.80M-74.08M-7.20M1.12M96.48M

ImageneBio Cash Flow Statement API

Pull ImageneBio's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=IMA&statement=CF&frequency=Quarter&period=all&api_key=YOUR_API_KEY